GranuFlo® and NaturaLyte® Dialysis Class Action Lawsuit

When deliberate negligence results in great harm to others

A quiet tragedy recently unfolded in the lives of the 400,000 Americans who must rely on kidney dialysis to sustain life. As a result, some suffered heart attacks or other sudden catastrophic health problems while being treated with the widely used dialysis products GranuFlo® and NaturaLyte®.

More than a few of them have died.

As a New York Times article reports, the European maker of GranuFlo® and NaturaLyte®, Fresenius Medical Care of Germany, had determined that improper use of its products appeared to be contributing to “a sharp increase in the risk of patients dying suddenly from cardiac arrest.”

But instead of immediately alerting clinics everywhere about the problem, only the company’s own dialysis centers were quietly informed, according to the Times.

Dialysis-Health-Care-Medicine

The bottom line is that many dialysis patients across our nation may have been subjected to heightened risk of developing metabolic alkalosis—a condition associated with low blood pressure, cardiac arrhythmia, heart attack, cardiac arrest, and other cardiovascular problems.

And it wasn’t until the U.S. Food & Drug Administration later became aware of the situation that it was remedied.

Now the company is rightly being held responsible for its staggering negligence. Victims can turn to Owen, Patterson & Owen for help.

If you or a loved one have been treated with GranuFlo® or NaturaLyte® and suffered a heart attack or death during or after dialysis treatment—you should consult with Owen, Patterson & Owen to determine if you qualify for potential compensation.

Start With a Free Consultation. Call us at 800.676.5295 or contact us to schedule a meeting to discuss your case with an experienced attorney.